Related Experiment Video

Updated: Jun 14, 2026

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
07:09

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Published on: April 1, 2015

[Platelet abnormalities in type 2 diabetes mellitus]

Cuauhtémoc Matadamas-Zárate1, Julia Hernández-Jerónimo, Eduardo Pérez-Campos

  • 1HGZ No. 1, IMSS, Facultad de Medicina, UABJO, Oaxaca, Oax.

Archivos De Cardiologia De Mexico
|April 6, 2010
PubMed

Insights

Platelets are crucial in diabetic vascular complications, exhibiting abnormalities like hypersensitivity and resistance to therapies. Understanding these platelet dysfunctions is key to managing diabetes-related cardiovascular risks.

Area of Science:

  • Cardiovascular Medicine
  • Endocrinology
  • Hematology

Context:

  • Diabetes mellitus is a global health concern, with vascular complications driving significant morbidity and mortality.
  • Diabetic patients experience accelerated atherothrombosis, exceeding that seen in other conditions.

Purpose:

  • To review platelet abnormalities associated with diabetes mellitus.
  • To explore the role of platelets in diabetic atherothrombosis and vascular complications.

Summary:

  • Diabetes mellitus is linked to numerous pro-thrombotic coagulation system abnormalities, including endothelial dysfunction, platelet hyperreactivity, and impaired fibrinolysis.
  • Platelets in diabetics show hypersensitivity to agonists, reduced response to antiplatelet drugs, and resistance to insulin, contributing to atherothrombosis.
  • These platelet dysfunctions may stem from hyperglycemia-induced toxic microenvironments or intrinsic platelet defects, suggesting platelets as a target for insulin resistance effects.

Impact:

  • Highlights platelets as a critical factor in the pathogenesis of diabetic vascular complications.
  • Suggests that targeting platelet abnormalities could offer novel therapeutic strategies for managing diabetes-related cardiovascular disease.

More Related Videos

Preparation of Washed Human Platelets for Quantitative Metabolic Flux Studies07:06

Preparation of Washed Human Platelets for Quantitative Metabolic Flux Studies

Published on: January 10, 2025

Related Concept Videos

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...